Cortexyme, Inc

(NASDAQ:CRTX)

Latest On Cortexyme, Inc (CRTX):

Date/Time Type Description Signal Details
2022-07-27 17:55 ESTNewsCortexyme to change name and ticker symbol next monthN/A
2022-05-11 02:18 ESTNewsCortexyme agrees to acquire biotech company NovosteoN/A
2022-03-08 11:50 ESTNewsCortexyme COR588 for bacterial infection shows safety in phase 1 trial preliminary dataN/A
2022-03-01 05:05 ESTNewsCortexyme: A Biotech Worth A Look Based On Potential Alzheimer's TreatmentN/A
2022-02-02 00:51 ESTNewsCortexyme outlines milestones for 2022N/A
2022-01-26 20:04 ESTNewsCortexyme stock plunges 34% after FDA places clinical hold on Alzheimer's drug applicationN/A
2021-12-27 11:49 ESTNewsCortexyme in pact with Jefferies to sell up to $150M worth of common stockN/A
2021-12-16 05:04 ESTNewsCortexyme: Drug Candidate COR588 May Offer Some Hope To InvestorsN/A
2021-11-17 15:22 ESTNewsCortexyme: A Challenging Path ForwardN/A
2021-11-12 00:01 ESTNewsCortexyme posts more data from Alzheimer’s trial to show benefit of its therapyN/A
2021-11-05 23:52 ESTNewsAlzheimer's - Cassava, Cortexyme Or Anavex: Who Will Come On Top?N/A
2021-11-02 14:31 ESTNewsWarning: CRTX is at high risk of performing badlyN/A
2021-11-01 17:42 ESTNewsCortexyme: Positive Lessons To Be Learned From Disappointing ResultsN/A
2021-10-31 22:28 ESTNewsOcugen among top healthcare gainers this week; Alzheimer’s setback hurts CortexymeN/A
2021-10-27 16:40 ESTNewsCortexyme says Alzheimer’s disease trial did not meet endpointsN/A
2021-10-27 16:38 ESTNewsCortexyme downgraded at BofA after setback in Alzheimer’s trialN/A
2021-10-11 09:23 ESTNewsCortexyme And The Gingipain Hypothesis Of Alzheimer's DiseaseN/A
2021-09-27 15:35 ESTNewsCortexyme slips as Citi doubts prospects of its lead candidate in Alzheimer’sN/A
2021-09-21 15:26 ESTNewsCanaccord doubles price target on Cortexyme, maintains buy ratingN/A
2021-09-12 08:04 ESTNewsCortexyme: Alzheimer's Readout In November A Binary EventN/A
2021-08-10 01:53 ESTNewsCortexyme EPS beats by $0.05N/A
2021-08-10 01:52 ESTNewsCortexyme up 23% as it expects top-line data from pivotal Alzheimer's trial in mid-NovemberN/A
2021-07-26 14:42 ESTNewsCortexyme data links bacteria to increased levels of tau protein associated with Alzheimer'sN/A
2021-07-23 17:10 ESTNewsCortexyme picks lead 3CLpro inhibitor for the treatment of COVID-19N/A
2021-07-22 21:42 ESTNewsCortexyme posts preclinical data from atuzaginstat periodontal disease trialN/A
2021-05-07 06:28 ESTNewsChecking In On CortexymeN/A
2021-03-03 11:26 ESTEarnings EstimateAn EPS average of -$3.35 is estimated for the 2022 year.Sell
2021-03-03 11:26 ESTEarnings EstimateAn EPS average of -$0.72 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-02 19:32 ESTFinancialsCompany financials have been released.Neutral
2021-02-17 19:28 ESTNewsCortexyme downgraded at Jefferies after clinical hold to Alzheimer’s trialN/A
2021-02-17 19:27 ESTNewsCortexyme: The OLE Study Hold Does Not MatterN/A
2021-02-17 11:20 ESTAnalyst RatingThe Analyst Target Price has decreased from $75.75 to $66.63.Neutral
2021-02-17 01:55 ESTNewsCortexyme plunges 24% on potential atuzaginstat safety signal in Alzheimer's studyN/A
2021-01-26 22:22 ESTNewsCortexyme to start testing its lead candidate in Parkinson’s diseaseN/A
2021-01-12 21:55 ESTNewsCortexyme: A Fresh Perspective In Alzheimer'sN/A
2021-01-11 07:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $83.71 to $75.75.Neutral
2020-12-13 03:43 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 21:28 ESTNewsCortexyme weighed down by Citi downgradeN/A
2020-12-07 07:25 ESTAnalyst RatingThe Analyst Target Price has increased from $80.43 to $83.71.Buy
2020-12-05 01:52 ESTNewsLate-stage study of Cortexyme's Alzheimer's med atuzaginstat passes interim tollgateN/A
2020-11-20 18:01 ESTNewsSeeking Alpha Catalyst WatchN/A
2020-11-20 11:31 ESTAnalyst RatingThe Analyst Target Price has increased from $78.86 to $80.43.Buy
2020-11-17 03:38 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 03:42 ESTEarnings EstimateAn EPS average of -$0.51 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-12 20:58 ESTNewsCortexyme reports Q3 resultsN/A
2020-11-07 15:30 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 12:27 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-05 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-08-24 04:27 ESTAnalyst RatingThe Analyst Target Price has increased from $78.14 to $78.86.Buy

About Cortexyme, Inc (CRTX):

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

CRTX Quotes by TradingView

See Advanced Chart

General

  • Name Cortexyme, Inc
  • Symbol CRTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 37
  • Fiscal Year EndDecember
  • IPO Date2019-05-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.cortexyme.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 6.34
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.85
  • Next Year EPS Estimate -$3.34
  • Next Quarter EPS Estimate -$0.70
  • Return on Assets -31%
  • Return on Equity -53%
  • Earnings Per Share -$3.17
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.03 billion
  • EBITDA -22279000
  • Analyst Target Price $66.63
  • Book Value Per Share $5.83
View More

Share Statistics

  • Shares Outstanding 29.55 million
  • Shares Float 19.24 million
  • % Held by Insiders 4568%
  • % Held by Institutions 55.64%
  • Shares Short 3.26 million
  • Shares Short Prior Month 2.72 million
  • Short Ratio 7.99
  • Short % of Float 21%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • 52 Week High $58.99
  • 52 Week Low $26.66
  • 50 Day Moving Average 38.54
  • 200 Day Moving Average 42.07
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Cortexyme, Inc (CRTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cortexyme, Inc (CRTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.69-$0.724.7%
2020-09-302020-11-12$N/A-$0.73-$0.61-20.01%
2020-06-302020-08-14$N/A-$0.60-$0.611.35%
2020-03-312020-05-12$N/A-$0.61-$0.44-37.17%
2019-12-312020-03-16$N/A-$0.35-$0.388.38%
2019-09-302019-11-12$N/A-$0.37-$0.370.48%
2019-06-302019-08-09$N/A-$0.57-$0.40-42.5%
2019-03-312019-06-12$N/A-$0.28-$0.23-21.96%

Cortexyme, Inc (CRTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A -16.98 million N/A 14.38 million 10.03 million
Income Before Tax N/A -21.51 million N/A -17.18 million -12.38 million
Selling General Administrative N/A 4.93 million N/A 3.48 million 2.92 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A -21.83 million N/A -17.78 million -12.95 million
Operating Income N/A -21.91 million N/A -17.86 million -12.95 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A 570000
Net Income From Continuing Operations N/A -21.51 million N/A -17.18 million -12.38 million
Net Income Applicable to Common Shares -20.56 million -21.51 million -17.61 million -17.18 million -12.38 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments 10.39 million N/A N/A 17.71 million 9.25 million
Change to Liabilities 2.64 million 137000 N/A 780000 -2.82 million
Total Cash Flow from Investing Activities 10.37 million -5.95 million -72.68 million 17.7 million 9.22 million
Net Borrowings N/A -3000 N/A -559000 N/A
Total Cash Flow from Financial Activities 90000 N/A 117.85 million -530000 N/A
Change to Operating Activities N/A -659000 N/A -12000 3.15 million
Change in Cash -1.91 million N/A 34.39 million 6.22 million 426000
Total Cash from Operating Activities -12.37 million -14.39 million -10.78 million -10.95 million -8.8 million
Depreciation 285000 N/A 83000 76000 59000
Other Cash Flow from Investing Activities N/A N/A -72.68 million N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A 117.69 million N/A N/A
Change to Net Income 4.16 million 3.66 million N/A 585000 670000
Capital Expenditures 20000 N/A 5000 9000 26000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A 16.65 million N/A 13.16 million 8.89 million
Total Stockholder Equity N/A 188.01 million N/A 218.04 million 115.48 million
Other Current Liabilities N/A 279000 N/A 53000 N/A
Total Assets N/A 204.66 million N/A 231.21 million 124.37 million
Common Stock 29000 29000 29000 29000 27000
Other Current Assets N/A 629000 N/A 954000 5.21 million
Retained Earnings -146.65 million -126.1 million -104.59 million -86.98 million -69.81 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 39000 N/A 244000 217000 217000
Cash N/A 64.25 million N/A 85.61 million 51.21 million
Total Current Liabilities 17 million 16.41 million N/A 13.11 million 8.89 million
Other Stockholder Equity 313000 513000 711000 -37000 60000
Property, Plant & Equipment 1.1 million 500000 1.25 million 1.26 million 1.33 million
Total Current Assets 137.86 million 142.97 million N/A 168.59 million 106.06 million
Long Term Investments N/A 60.13 million N/A 61.14 million 16.76 million
Net Tangible Assets 172.26 million 188.01 million 205.47 million N/A 115.48 million
Short Term Investments N/A 73.55 million N/A 76.81 million 48.65 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 3.56 million 4.31 million N/A 4.95 million 3.08 million

Cortexyme, Inc (CRTX) Chart:

Cortexyme, Inc (CRTX) News:

Below you will find a list of latest news for Cortexyme, Inc (CRTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cortexyme, Inc (CRTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest CRTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$2.7
Jun 13, 2022 7:59 PM EST46$2.71
Jun 13, 2022 7:59 PM EST58$2.71
Jun 13, 2022 7:59 PM EST5$2.71
Jun 13, 2022 7:59 PM EST29$2.71

Cortexyme, Inc (CRTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945320000005/0001779453-20-000005-index.htm
2019-04-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1662774/000000000019006433/0000000000-19-006433-index.htm
2019-04-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1662774/000000000019007584/0000000000-19-007584-index.htm
2020-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1662774/000000000020003043/0000000000-20-003043-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000007800319000023/0000078003-19-000023-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000007800319000027/0000078003-19-000027-index.htm
2019-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000007800319000032/0000078003-19-000032-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000007800320000038/0000078003-20-000038-index.htm
2019-03-04DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1662774/000095012319002560/0000950123-19-002560-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000106823820000050/0001068238-20-000050-index.htm
2019-04-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1662774/000119312519105299/0001193125-19-105299-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1662774/000119312519105445/0001193125-19-105445-index.htm
2019-04-16S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1662774/000119312519107092/0001193125-19-107092-index.htm
2019-04-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1662774/000119312519123571/0001193125-19-123571-index.htm
2019-04-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1662774/000119312519123577/0001193125-19-123577-index.htm
2019-04-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1662774/000119312519123580/0001193125-19-123580-index.htm
2019-05-018-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1662774/000119312519131785/0001193125-19-131785-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1662774/000119312519138179/0001193125-19-138179-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1662774/000119312519138185/0001193125-19-138185-index.htm
2019-05-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1662774/000119312519142424/0001193125-19-142424-index.htm
2019-05-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1662774/000119312519143164/0001193125-19-143164-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312519145468/0001193125-19-145468-index.htm
2019-05-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000119312519151456/0001193125-19-151456-index.htm
2019-09-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000119312519257972/0001193125-19-257972-index.htm
2019-09-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000119312519257980/0001193125-19-257980-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312520026290/0001193125-20-026290-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1662774/000119312520074898/0001193125-20-074898-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312520075778/0001193125-20-075778-index.htm
2020-04-07S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1662774/000119312520100556/0001193125-20-100556-index.htm
2020-04-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1662774/000119312520102554/0001193125-20-102554-index.htm
2020-04-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1662774/000119312520105265/0001193125-20-105265-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312520128936/0001193125-20-128936-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312520140538/0001193125-20-140538-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312520148723/0001193125-20-148723-index.htm
2020-06-01S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1662774/000119312520157335/0001193125-20-157335-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1662774/000119312520165699/0001193125-20-165699-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028323/0001209191-19-028323-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028325/0001209191-19-028325-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028326/0001209191-19-028326-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028328/0001209191-19-028328-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028329/0001209191-19-028329-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028330/0001209191-19-028330-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028331/0001209191-19-028331-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028332/0001209191-19-028332-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028333/0001209191-19-028333-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028334/0001209191-19-028334-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028335/0001209191-19-028335-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028337/0001209191-19-028337-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028340/0001209191-19-028340-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119028537/0001209191-19-028537-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119029476/0001209191-19-029476-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119029477/0001209191-19-029477-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119029480/0001209191-19-029480-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919119046227/0001209191-19-046227-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008064/0001209191-20-008064-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008065/0001209191-20-008065-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008066/0001209191-20-008066-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008068/0001209191-20-008068-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008069/0001209191-20-008069-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008070/0001209191-20-008070-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120008073/0001209191-20-008073-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120018537/0001209191-20-018537-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120018550/0001209191-20-018550-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120018558/0001209191-20-018558-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120023626/0001209191-20-023626-index.htm
2020-05-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120029809/0001209191-20-029809-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120029819/0001209191-20-029819-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120030020/0001209191-20-030020-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120030022/0001209191-20-030022-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120032970/0001209191-20-032970-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/0001209191-20-035104-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120035419/0001209191-20-035419-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120035421/0001209191-20-035421-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120035423/0001209191-20-035423-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120035424/0001209191-20-035424-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000120919120035425/0001209191-20-035425-index.htm
2019-05-06CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1662774/000135445719000252/0001354457-19-000252-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000142284820000029/0001422848-20-000029-index.htm
2019-06-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662774/000156459019022340/0001564590-19-022340-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662774/000156459019031260/0001564590-19-031260-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662774/000156459019042988/0001564590-19-042988-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1662774/000156459020011165/0001564590-20-011165-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1662774/000156459020017899/0001564590-20-017899-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1662774/000156459020017901/0001564590-20-017901-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662774/000156459020024670/0001564590-20-024670-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1662774/000156459020040300/0001564590-20-040300-index.htm
2016-01-05DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000166277416000002/0001662774-16-000002-index.htm
2017-02-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000166277417000001/0001662774-17-000001-index.htm
2018-05-31DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000166277418000001/0001662774-18-000001-index.htm
2019-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000177162019000002/0001771620-19-000002-index.htm
2019-06-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000177162019000003/0001771620-19-000003-index.htm
2020-01-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1662774/000177162020000001/0001771620-20-000001-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945119000001/0001779451-19-000001-index.htm
2019-06-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000001/0001779453-19-000001-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000002/0001779453-19-000002-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000003/0001779453-19-000003-index.htm
2019-11-293/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000004/0001779453-19-000004-index.htm
2019-11-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000005/0001779453-19-000005-index.htm
2019-11-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000006/0001779453-19-000006-index.htm
2019-11-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945319000007/0001779453-19-000007-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945320000001/0001779453-20-000001-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945320000002/0001779453-20-000002-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1662774/000177945320000005/0001779453-20-000005-index.htm
2019-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1662774/999999999519001050/9999999995-19-001050-index.htm
2020-04-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1662774/999999999520000739/9999999995-20-000739-index.htm

Cortexyme, Inc (CRTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cortexyme, Inc (CRTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 4568%
Institutional Ownership: 5564%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-10David LamondDirectorBuy30,000.0050.001,500,000.001,653,336.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120008073/0001209191-20-008073-index.htm
2020-05-15David LamondDirectorBuy1,263.0046.3058,477.781,654,599.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-15David LamondDirectorBuy985.0048.3747,639.531,655,584.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-15David LamondDirectorBuy1,600.0048.9678,333.441,657,184.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-15David LamondDirectorBuy1,000.0050.7150,707.301,658,184.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-15David LamondDirectorBuy500.0052.2026,100.501,658,684.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-15David LamondDirectorBuy100.0053.105,310.001,658,784.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-19David LamondDirectorBuy400.0054.0921,636.001,659,184.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-19David LamondDirectorBuy5,906.0055.42327,308.751,665,090.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-05-19David LamondDirectorBuy32,894.0056.421,855,738.041,697,984.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120030688/0001209191-20-030688-index.htm
2020-06-04David LamondDirectorBuy13,609.0042.13573,377.111,711,593.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/0001209191-20-035104-index.htm
2020-06-04David LamondDirectorBuy10,642.0043.32461,033.791,722,235.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/0001209191-20-035104-index.htm
2020-02-07Michael J. DetkeChief Medical OfficerBuy17,231.006.91119,066.2117,231.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120008070/0001209191-20-008070-index.htm
2020-06-04David LamondDirectorBuy24,874.0043.881,091,384.061,747,109.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120035104/0001209191-20-035104-index.htm
2020-04-02Michael J. DetkeChief Medical OfficerBuy5,515.006.9138,108.6522,746.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120023626/0001209191-20-023626-index.htm
2019-05-10EPIQ Capital Group, LLCInsiderBuy4,350.0026.41114,883.502,822,546.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000002/0001779453-19-000002-index.htm
2020-05-27Michael J. DetkeChief Medical OfficerBuy5,515.006.9138,108.6528,261.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120032970/0001209191-20-032970-index.htm
2019-05-10EPIQ Capital Group, LLCInsiderBuy4,170.0027.58115,008.602,826,716.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000002/0001779453-19-000002-index.htm
2019-05-10EPIQ Capital Group, LLCInsiderBuy80.0027.052,164.002,826,796.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000002/0001779453-19-000002-index.htm
2019-08-16EPIQ Capital Group, LLCInsiderBuy700.0026.3718,459.982,827,496.00https://www.sec.gov/Archives/edgar/data/1662774/000177945119000001/0001779451-19-000001-index.htm
2019-08-19EPIQ Capital Group, LLCInsiderBuy2,100.0026.5055,639.922,829,596.00https://www.sec.gov/Archives/edgar/data/1662774/000177945119000001/0001779451-19-000001-index.htm
2019-08-20EPIQ Capital Group, LLCInsiderBuy600.0025.6915,414.002,830,196.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000003/0001779453-19-000003-index.htm
2019-08-20EPIQ Capital Group, LLCInsiderBuy2,310.0025.6959,343.902,832,506.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000003/0001779453-19-000003-index.htm
2019-08-21EPIQ Capital Group, LLCInsiderBuy420.0024.8710,444.772,832,926.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000003/0001779453-19-000003-index.htm
2019-08-21EPIQ Capital Group, LLCInsiderBuy1,635.0024.8740,660.002,834,561.00https://www.sec.gov/Archives/edgar/data/1662774/000177945319000003/0001779453-19-000003-index.htm
2020-05-20EPIQ Capital Group, LLCInsiderBuy5,668.0058.00328,744.002,848,905.00https://www.sec.gov/Archives/edgar/data/1662774/000177945320000002/0001779453-20-000002-index.htm
2020-05-20EPIQ Capital Group, LLCInsiderBuy417.0057.2223,860.742,849,322.00https://www.sec.gov/Archives/edgar/data/1662774/000177945320000002/0001779453-20-000002-index.htm
2020-05-21EPIQ Capital Group, LLCInsiderBuy520.0055.8029,016.002,849,842.00https://www.sec.gov/Archives/edgar/data/1662774/000177945320000002/0001779453-20-000002-index.htm
2020-05-22EPIQ Capital Group, LLCInsiderBuy2,085.0055.90116,551.502,851,927.00https://www.sec.gov/Archives/edgar/data/1662774/000177945320000002/0001779453-20-000002-index.htm
2020-06-11EPIQ Capital Group, LLCInsiderBuy6,600.0044.32292,512.002,858,527.00https://www.sec.gov/Archives/edgar/data/1662774/000177945320000005/0001779453-20-000005-index.htm
2020-06-12EPIQ Capital Group, LLCInsiderBuy2,440.0044.06107,506.402,860,967.00https://www.sec.gov/Archives/edgar/data/1662774/000177945320000005/0001779453-20-000005-index.htm
2019-05-13UNA S RYANDirectorBuy2,875.0017.0048,875.002,875.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120018550/0001209191-20-018550-index.htm
2020-06-03PFIZER INC10% Share HolderSell370,000.0040.1814,866,600.002,879,973.00https://www.sec.gov/Archives/edgar/data/1662774/000007800320000038/0000078003-20-000038-index.htm
2019-05-13KEVIN YOUNGDirectorBuy30,000.0017.00510,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120018558/0001209191-20-018558-index.htm
2019-05-13PFIZER INC10% Share HolderBuy50,000.0017.00850,000.003,249,973.00https://www.sec.gov/Archives/edgar/data/1662774/000007800319000027/0000078003-19-000027-index.htm
2019-05-13Margaret McLoughlinDirectorBuy550.0017.009,350.00550.00https://www.sec.gov/Archives/edgar/data/1662774/000120919120018537/0001209191-20-018537-index.htm